MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY

/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2021. First Quarter Fiscal...

Related Keywords

United States ,Cincinnati ,Ohio ,America ,Charlie Wood ,Jack Kenny ,Julie Smith ,Prnewswire Meridian Bioscience Inc ,Drug Administration ,Company Leadcare ,Nasdaq ,A Risk Factors Of The Company ,Exchange Commission ,Meridian Bioscience Inc ,Securities Exchange ,Quarter Fiscal ,First Quarter Fiscal ,Emergency Use Authorization ,Chief Executive Officer ,Life Science ,Senior Vice President ,Principal Accounting Officer ,Operating Margin ,Net Earnings Per Share ,Diluted Basis ,Investor Relations ,Share Data ,Financial Measures ,Consolidated Balance Sheet Data ,Latin America ,Middle East ,Net Earnings ,Common Share ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Meridian Bioscience ,United States Food ,Risk Factors ,Annual Report ,Federal Food ,Cosmetic Act ,Select Market ,Nc ,